Property Name |
Property Value |
Unit |
Raw Value |
Raw Unit |
Annotation |
Factor |
Reference |
AUC |
18193.0 |
ng.h/ml |
18193.0 |
ng.h/ml |
PO, oral; |
|
DRUGBANK |
Bioavailability |
77.0 |
% |
63-91 |
% |
PO, oral; |
|
DRUGBANK |
Bioavailability |
81.0 |
% |
81±6 |
% |
PO, oral; |
|
The Pharmacological Basis of Therapeutics |
C Max |
1470.0 |
ng/ml |
1.47±0.16 |
mcg/ml |
PO, oral; food; |
food ↓ ; |
DRUGBANK |
C Max |
1880.0 |
ng/ml |
1.88±0.42 |
mcg/ml |
PO, oral; fasting; |
|
DRUGBANK |
C Max |
1500.0 |
ng/ml |
1.5±0.2 |
mcg/ml |
Capsule, PO, Oral; food; adults; normal,healthy; |
|
The Pharmacological Basis of Therapeutics |
T Max |
8.0 |
h |
8 |
h |
Oral single dose; |
|
DRUGBANK |
T Max |
2.0 |
h |
2.0±1.5 |
h |
Capsule, PO, Oral; food; adults; normal,healthy; |
|
The Pharmacological Basis of Therapeutics |
Clearance |
5.1 |
L/h |
5.1 |
L/h |
Total clearance; Elderly; fasting; |
|
DRUGBANK |
Clearance |
5.3 |
L/h |
5.3±0.9 |
L/h |
Total clearance; normal,healthy; patients; |
|
DRUGBANK |
Clearance |
0.13 |
L/h/kg |
2.1±0.1 |
ml/min/kg |
hydrolysis; |
Elderly ↓ ;Obesity ↓ ; |
The Pharmacological Basis of Therapeutics |
Clearance |
0.0840 |
L/h/kg |
1.4 |
ml/min/kg |
intravenous injection, IV; human, homo sapiens; |
|
Human Intravenous Pharmacokinetic Dataset |
Volume of Distribution |
0.84 |
L/kg |
0.84±0.16 |
L/kg |
Single dose; |
|
DRUGBANK |
Volume of Distribution |
0.66 |
L/kg |
0.47-0.84 |
L/kg |
|
|
DRUGBANK |
Volume of Distribution |
1.0 |
L/kg |
1.0±0.1 |
L/kg |
Apparent volume of distribution; hydrolysis; |
Elderly ↑ ;Obesity ↑ ; |
The Pharmacological Basis of Therapeutics |
Volume of Distribution |
0.52 |
L/kg |
0.52 |
L/kg |
intravenous injection, IV; human, homo sapiens; |
|
Human Intravenous Pharmacokinetic Dataset |
Half-life |
6.0 |
h |
6 |
h |
elimination half-life; young; |
|
DRUGBANK |
Half-life |
13.6 |
h |
13.6 |
h |
elimination half-life; Elderly; |
|
DRUGBANK |
Half-life |
7.3 |
h |
7.3±0.8 |
h |
elimination half-life; normal,healthy; Single dose; |
|
DRUGBANK |
Half-life |
4.5 |
h |
3-6 |
h |
distribution half-life; |
|
DRUGBANK |
Half-life |
7.0 |
h |
5-9 |
h |
elimination half-life; |
|
DRUGBANK |
Half-life |
5.9 |
h |
5.9±0.4 |
h |
|
Obesity ↑ ;Age ↑ ; |
The Pharmacological Basis of Therapeutics |
Half-life |
7.3 |
h |
7.3 |
h |
intravenous injection, IV; human, homo sapiens; |
|
Human Intravenous Pharmacokinetic Dataset |
Toxicity LD50 |
690.0 |
mg/kg |
690.0 |
mg/kg |
PO, oral; Rattus, Rat; |
|
DRUGBANK |
Toxicity LD50 |
96.0 |
mg/kg |
96.0 |
mg/kg |
intravenous injection, IV; mouse; |
|
T3DB |
Eliminate Route |
65.0 |
% |
~60-70 |
% |
Urinary excretion; |
|
DRUGBANK |
Eliminate Route |
19.0 |
% |
9-29 |
% |
Faeces excretion; |
|
DRUGBANK |
Eliminate Route |
1.0 |
% |
<1 |
% |
Urinary excretion; PO, oral; Unchanged drug; |
|
DRUGBANK |
Eliminate Route |
1.0 |
% |
<1 |
% |
Urinary excretion; Unchanged drug; |
|
The Pharmacological Basis of Therapeutics |
Protein Binding |
92.0 |
% |
89-95 |
% |
plasma proteins; |
|
DRUGBANK |
Protein Binding |
93.0 |
% |
93 |
% |
|
|
The Pharmacological Basis of Therapeutics |